Adaptive Immune Responses During Pregnancy

American Journal of Reproductive Immunology

Volumn 69, Issue 4, 2013, Pages 291-303

  Zenclussen, Ana Claudia ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Adaptive immunity; Cells; Chemokines; Placenta; Pregnancy; Treg

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FETAL ANTIGEN; GALECTIN; MATERNAL ANTIBODY; MINOR HISTOCOMPATIBILITY ANTIGEN;

ACTIVE IMMUNIZATION; ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL SUBPOPULATION; CYTOKINE RELEASE; HORMONE SYNTHESIS; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOLOGY; MEDICAL SOCIETY; MICROENVIRONMENT; MOTHER; NONHUMAN; PATERNAL LYMPHOCYTE IMMUNIZATION; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REPRODUCTION; REVIEW; SEMINAL PLASMA; TH1 TH2 BALANCE; TH17 CELL;

ADAPTIVE IMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FETUS; HISTOCOMPATIBILITY, MATERNAL-FETAL; HUMANS; IMMUNE TOLERANCE; PLACENTA; PREGNANCY; T-LYMPHOCYTES, REGULATORY; TH1-TH2 BALANCE;

EID: 84875056258     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12097     Document Type: Review

References (121)

1. Medawar PB: Some Immunological and Endcrinological Problems Raised by Evolution of Viviparity in Vertebrates. (ed) by Symposia of the Society for Experimental Biology. London, UK, Syndics of the Cambridge University Press, 1953.
2. Adams KM, Nelson JL: Bi-directional cell traficking during pregnancy. In Immunology of Pregnancy, G Mor (ed). Immunology of Pregnancy. Georgetown, Texas, USA, Landes Bioscience/Eurekah, 2006.
3. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA: Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996; 93:705-708.
4. Lo YM, Lo ES, Watson N, Noakes L, Sargent IL, Thilaganathan B, Wainscoat JS: Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996; 88:4390-4395.
5. Maloney S, Smith A, Furst DE, Myerson D, Rupert K, Evans PC, Nelson JL: Microchimerism of maternal origin persists into adult life. J Clin Invest 1999; 104:41-47.
6. Khosrotehrani K, Johnson KL, Guégan S, Stroh H, Bianchi S: Natural history of fetal cell microchimerism during and following murine pregnancy. J Reprod Immunol 2005; 66:1-12.
7. Zenclussen ML, Thuere C, Ahmad N, Wafula PO, Fest S, Teles A, Leber A, Casalis PA, Bechmann I, Priller J, Volk HD, Zenclussen AC: The persistence of paternal antigens in the maternal body is involved in regulatory T-cell expansion and fetal-maternal tolerance in murine pregnancy. Am J Reprod Immunol 2010; 63:200-208.
8. Elbe-Bürger A, Mommaas AM, Prieschl EE, Fiebiger E, Baumruker T, Stingl G: Major histocompatibility complex class II- fetal skin dendritic cells are potent accesory cells of polyclonal T-cell responses. Immunology 2000; 101:242-253.
9. Mold JE, Michaëlsson J, Burt TD, Muench MO, Beckerman KP, Busch MP, Lee TH, Nixon DF, McCune JM: Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008; 322:1562-1565.
10. Sargent IL, Germain SJ, Sacks GP, Kumar S, Redman CW: Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol 2003; 59:153-160.
11. Tafuri A, Alferink J, Möller P, Hämmerling GJ, Arnold B: T cell awareness of paternal alloantigens during pregnancy. Science 1995; 270:630-633.
12. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-1164.
13. Goulmy E, Gratama JW, Blokland E, Zwaan FE, van Rood JJ: A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature 1983; 302:159-161.
14. Kircher B, Stevanovic S, Urbanek M, Mitterschiffthaler A, Rammensee HG, Grünewald K, Gastl G, Nachbaur D: Induction of HA-1-specific cytotoxic T-cell clones parallels the therapeutic effect of donor lymphocyte infusion. Br J Haematol 2002; 117:935-939.
15. Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM, Loberiza FR, Porter DL: Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12:758-769.
16. Aluvihare VR, Kallikourdis M, Betz AG: Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5:266-271.
17. Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T, Kotsch K, Leber J, Volk HD: Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4 + CD25 + T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 2005; 166:811-822.
18. Zenclussen AC: CD4(+)CD25 + T regulatory cells in murine pregnancy. J Reprod Immunol 2005; 65:101-110.
19. Robertson SA, Guerin LR, Bromfield JJ, Branson KM, Ahlström AC, Care AS: Seminal fluid drives expansion of the CD4 + CD25 + T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod 2009; 80:1036-1045.
20. Saito S, Sasaki Y, Sakai M: CD4(+)CD25high regulatory T cells in human pregnancy. J Reprod Immunol 2005; 65:111-120.
21. Samstein RM, Josefowicz SZ, Arvey A, Treuting PM, Rudensky AY: Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 2012; 150:29-38.
22. Shima T, Sasaki Y, Itoh M, Nakashima A, Ishii N, Sugamura K, Saito S: Regulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic mice. J Reprod Immunol 2010; 85:121-129.
23. Schumacher A, Wafula PO, Bertoja AZ, Sollwedel A, Thuere C, Wollenberg I, Yagita H, Volk HD, Zenclussen AC: Mechanisms of action of regulatory T cells specific for paternal antigens during pregnancy. Obstet Gynecol 2007; 110:1137-1145.
24. Robertson SA, Sharkey DJ: The role of semen in induction of maternal immune tolerance to pregnancy. Semin Immunol 2001; 13:243-254.
25. Robertson SA, Mau VJ, Tremellen KP, Seamark RF: Role of high molecular weight seminal vesicle proteins in eliciting the uterine inflammatory response to semen in mice. J Reprod Fertil 1996; 107:265-277.
26. Blois SM, Kammerer UAlba Soto C, Tometten MC, Shaikly V, Barrientos G, Jurd R, Rukavina D, Thomson AW, Klapp BF, Fernández N, Arck PC: Dendritic cells: key to fetal tolerance? Biol Reprod 2007; 77:590-598.
27. Schumacher A, Wafula PO, Teles A, El-Mousleh T, Linzke N, Zenclussen ML, Langwisch S, Heinze K, Wollenberg I, Casalis PA, Volk HD, Fest S, Zenclussen AC: Blockage of heme oxygenase-1 abrogates the protective effect of regulatory T cells on murine pregnancy and promotes the maturation of dendritic cells. PLoS ONE 2012; 7:e42301. doi:10.1371/journal.pone.0042301.
28. Remes Lenicov F, Rodriguez Rodrigues C, Sabatté J, Cabrini M, Jancic C, Ostrowski M, Merlotti A, Gonzalez H, Alonso A, Pasqualini RA, Davio C, Geffner J, Ceballos A: Semen promotes the differentiation of tolerogenic dendritic cells. J Immunol 2012; 189:4777-4786.
29. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S: Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat Med 1998; 4:1020-1024.
30. Raghupathy R: Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol 2001; 13:219-227.
31. Svensson L, Arvola M, Sällström MA, Holmdahl R, Mattsson R: The Th2 cytokines IL-4 and IL-10 are not crucial for the completion of allogeneic pregnancy in mice. J Reprod Immunol 2001; 51:3-7.
32. Fallon PG, Jolin HE, Smith P, Emson CL, Townsend MJ, Fallon R, Smith P, McKenzie AN: IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. Immunity 2002; 17:7-17.
33. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4 + CD25 + regulatory T cells. Nat Immunol 2003; 4:330-336.
34. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT: Normal human pregnancy is associated with an elevation in the immune suppressive CD25 + CD4 + regulatory T-cell subset. Immunology 2004; 112:38-43.
35. Arruvito L, Sanz M, Banham AH, Fainboim L: Expansion of CD4 + CD25 + and FOXP3 + regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 2007; 178:2572-2578.
36. Guerin LR, Prins JR, Robertson SA: Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update 2009; 15:517-535.
37. Saito S, Shima T, Nakashima A, Shiozaki A, Ito M, Sasaki Y: What is the role of regulatory T cells in the success of implantation and early pregnancy? J Assist Reprod Genet 2007; 24:379-386.
38. Thuere C, Zenclussen ML, Schumacher A, Langwisch S, Schulte-Wrede U, Teles A, Paeschke S, Volk HD, Zenclussen AC: Kinetics of regulatory T cells during murine pregnancy. Am J Reprod Immunol 2007; 58:514-523.
39. Robertson SA, Guerin LR, Moldenhauer LM, Hayball JD: Activating T regulatory cells for tolerance in early pregnancy - the contribution of seminal fluid. J Reprod Immunol 2009; 83:109-116.
40. Clark DA, Fernandes J, Banwatt D: Prevention of spontaneous abortion in the CBA x DBA/2 mouse model by intravaginal TGF-beta and local recruitment of CD4 + 8 + FOXP3 + cells. Am J Reprod Immunol 2008; 59:525-534.
41. Zhao JX, Zeng YY, Liu Y: Fetal alloantigen is responsible for the expansion of the CD4(+)CD25(+) regulatory T cell pool during pregnancy. J Reprod Immunol 2007; 75:71-81.
42. Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA, Claas FH: Evidence for a selective migration of fetus-specific CD4 + CD25 bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol 2008; 180:5737-5745.
43. Zenclussen AC, Gerlof K, Zenclussen ML, Ritschel S, Zambon Bertoja A, Fest S, Hontsu S, Ueha S, Matsushima K, Leber J, Volk HD: Regulatory T cells induce a privileged tolerant microenvironment at the fetal-maternal interface. Eur J Immunol 2006; 36:82-94.
44. Wafula PO, Teles A, Schumacher A, Pohl K, Yagita H, Volk HD, Zenclussen AC: PD-1 but not CTLA-4 blockage abrogates the protective effect of regulatory T cells in a pregnancy murine model. Am J Reprod Immunol 2009; 62:283-292.
45. Miwa N, Hayakawa S, Miyazaki S, Myojo S, Sasaki Y, Sakai M, Takikawa O, Saito S: IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod 2005; 11:865-870.
46. Amsalem H, Gaiger A, Mizrahi S, Yagel S, Rachmilewitz J: Characterization of a lymphocyte subset displaying a unique regulatory activity in human decidua. Int Immunol 2008; 20:1147-1154.
47. Ochanuna Z, Geiger-Maor A, Dembinsky-Vaknin A, Karussis D, Tykocinski ML, Rachmilewitz J: Inhibition of effector function but not T cell activation and increase in FoxP3 expression in T cells differentiated in the presence of PP14. PLoS ONE 2010; 5:e12868.
48. Saito S, Nakashima A, Ito M, Shima T: Clinical implication of recent advances in our understanding of IL-17 and reproductive immunology. Expert Rev Clin Immunol 2011; 7:649-657.
49. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J: The predominance of Th1 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol 2012; 93:75-81.
50. Michaëlsson J, Mold JE, McCune JM, Nixon DF: Regulation of T cell responses in the developing human fetus. J Immunol 2006; 176:5741-5748.
51. Polanczyk MJ, Carson BD, Subramanian S, Afentoulis M, Vandenbark AA, Ziegler SF, Offner H: Cutting edge: estrogen drives expansion of the CD4 + CD25 + regulatory T cell compartment. J Immunol 2004; 173:2227-2230.
52. Wang C, Dehghani B, Li Y, Kaler LJ, Vandenbark AA, Offner H: Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology 2009; 126:329-335.
53. Piccinni MP, Giudizi MG, Biagiotti R, Beloni L, Giannarini L, Sampognaro S, Parronchi P, Manetti R, Annunziato F, Livi C, et al.: Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 1995; 155:128-133.
54. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, Cordo-Russo R, Toscano MA, Bianco GA, Kobelt P, Handjiski B, Tirado I, Markert UR, Klapp BF, Poirier F, Szekeres-Bartho J, Rabinovich GA, Arck PC: A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007; 13:1450-1457.
55. Joachim R, Zenclussen AC, Polgar B, Douglas AJ, Fest S, Knackstedt M, Klapp BF, Arck PC: The progesterone derivative dydrogesterone abrogates murine stress-triggered abortion by inducing a Th2 biased local immune response. Steroids 2003; 68:931-940.
56. Hudić I, Szekeres-Bartho J, Fatušić Z, Stray-Pedersen B, Dizdarević-Hudić L, Latifagić A, Hotić N, Kamerić L, Mandžić A: Dydrogesterone supplementation in women with threatened preterm delivery-the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor. J Reprod Immunol 2011; 92:103-107.
57. Jensen F, Woudwyk M, Teles A, Woidacki K, Taran F, Costa S, Malfertheiner SF, Zenclussen AC: Estradiol and progesterone regulate the migration of mast cells from the periphery to the uterus and induce their maturation and degranulation. PLoS ONE 2010; 5:e14409.
58. Woidacki K, Popovic M, Metz M, Schumacher A, Linzke N, Teles A, Poirier F, Fest S, Jensen F, Rabinovich GA, Maurer M, Zenclussen AC: Mast cells rescue implantation defects caused by c-kit deficiency. Cell Death Dis 2013; 4:e462.
59. Schumacher A, Brachwitz N, Sohr S, Engeland K, Langwisch S, Dolaptchieva M, Alexander T, Taran A, Malfertheiner SF, Costa SD, Zimmermann G, Nitschke C, Volk HD, Alexander H, Gunzer M, Zenclussen AC: Human chorionic gonadotropin attracts regulatory T cells into the fetal-maternal interface during early human pregnancy. J Immunol 2009; 182:5488-5497.
60. Schumacher A, Heinze K, Witte J, Poloski E, Linzke N, Woidacki K, Zenclussen AC: Human Chorionic Gonadotropin as a central regulator of pregnancy immune tolerance. J Immunol 2013.
61. Ramhorst R, Fraccaroli L, Aldo P, Alvero AB, Cardenas I, Leirós CP, Mor G: Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells. Am J Reprod Immunol 2012; 67:17-27.
62. Nancy P, Tagliani E, Tay CS, Asp P, Levy DE, Erlebacher A: Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface. Science 2012; 336:1317-1321.
63. Rabinovich GA, Ramhorst RE, Rubinstein N, Corigliano A, Daroqui MC, Kier-Joffé EB, Fainboim L: Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms. Cell Death Differ 2002; 9:661-670.
64. Fraccaroli L, Alfieri J, Larocca L, Calafat M, Mor G, Leirós CP, Ramhorst R: A potential tolerogenic immune mechanism in a trophoblast cell line through the activation of chemokine-induced T cell death and regulatory T cell modulation. Hum Reprod 2009; 24:166-175.
65. Lara-Marquez M, O'Dorisio M, O'Dorisio T, Shah M, Karacay B: Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells. J Immunol 2001; 166:2522-2530.
66. Hill JM, McCune SK, Alvero RJ, Glazner GW, Henins KA, Stanziale SF, Keimowitz JR, Brenneman DE: Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent. J Clin Invest 1996; 97:202-208.
67. Lim MA, Stack CM, Cuasay K, Stone MM, McFarlane HG, Waschek JA, Hill JM: Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior. Int J Dev Neurosci 2008; 26:423-434.
68. Roca V, Calafat M, Larocca L, Ramhorst R, Farina M, Franchi AM, Leirós CP: Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice. Reproduction 2009; 138:733-742.
69. Rabinovich GA, Croci DO: Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity 2012; 36:322-335.
70. Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y: Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999; 190:385-398.
71. Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, Hernandez SF, Bassil R, Croci DO, Cerliani JP, Delacour D, Wang Y, Elyaman W, Khoury SJ, Rabinovich GA: Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 2012; 37:249-263.
72. Seropian IM, Cerliani JP, Toldo S, Van Tassell BW, Ilarregui JM, González GE, Matoso M, Salloum FN, Melchior R, Gelpi RJ, Stupirski JC, Benatar A, Gómez KA, Morales C, Abbate A, Rabinovich GA: Galectin-1 controls cardiac inflammation and ventricular remodeling during acute myocardial infarction. Am J Pathol 2013; 182:29-40.
73. Soldati R, Berger E, Zenclussen AC, Jorch G, Lode HN, Salatino M, Rabinovich GA, Fest S: Neuroblastoma triggers an immunoevasive program involving galectin-1-dependent modulation of T cell and dendritic cell compartments. Int J Cancer 2012; 131:1131-1141.
74. Iglesias MM, Rabinovich GA, Ivanovic V, Sotomayor C, Wolfenstein-Todel C: Galectin-1 from ovine placenta-amino-acid sequence, physicochemical properties and implications in T-cell death. Eur J Biochem 1998; 252:400-407.
75. Jeschke U, Toth B, Scholz C, Friese K, Makrigiannakis A: Glycoprotein and carbohydrate binding protein expression in the placenta in early pregnancy loss. J Reprod Immunol 2010; 85:99-105.
76. Kopcow HD, Rosetti F, Leung Y, Allan DS, Kutok JL, Strominger JL: T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1. Proc Natl Acad Sci U S A 2008; 105:18472-18477.
77. Poirier F, Robertson EJ: Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin. Development 1993; 119:1229-1236.
78. Poss K, Tonegawa S: Reduced stress defense in heme oxygenase-1 deficient cells. Proc Natl Acad Sci U S A 1997; 94:10925-10930.
79. Zenclussen ML, Casalis PA, El-Mousleh T, Rebelo S, Langwisch S, Linzke N, Volk HD, Fest S, Soares MP, Zenclussen AC: Haem oxygenase-1 dictates intrauterine fetal survival in mice via carbon monoxide. J Pathol 2011; 225:293-304.
80. Zenclussen ML, Jensen F, Rebelo S, El-Mousleh T, Casalis PA, Zenclussen AC: Heme oxygenase-1 expression in the ovary dictates a proper oocyte ovulation, fertilization, and corpora lutea maintenance. Am J Reprod Immunol 2012; 67:376-382.
81. Wessells J, Wessner D, Parsells R, White K, Finkenzeller D, Zimmermann W, Dveksler G: Pregnancy specific glycoprotein 18 induces IL-10 expression in murine macrophages. Eur J Immunol 2000; 30:1830-1840.
82. Motran CC, Diaaz FL, Gruppi A, Slavin D, Chatton B, Bocco JL: Human pregnancy-specific glycoprotein 1a (PSG1a) induces alternative activation in human and mouse monocytes and suppresses the accessory cell-dependent T cell proliferation. J Leukoc Biol 2002; 72:512-521.
83. Zhou GQ, Hammarström S: Pregnancy-specific glycoprotein (PSG) in baboon (Papio hamadryas): family size, domain structure, and prediction of a functional region in primate PSGs. Biol Reprod 2001; 64:90-99.
84. Martinez FF, Knubel CP, Sanchez MC, Cervi L, Motran CC: Pregnancy-specific glycoprotein 1a activates dendritic cells to provide signals for Th17-, Th2-, and Treg-cell polarization. Eur J Immunol 2012; 42:1573-1584.
85. Wu JA, Johnson BL, Chen Y, Ha CT, Dveksler GS: Murine pregnancy-specific glycoprotein 23 induces the proangiogenic factors transforming-growth factor beta 1 and vascular endothelial growth factor a in cell types involved in vascular remodeling in pregnancy. Biol Reprod 2008; 79:1054-1061.
86. Ha CT, Wu JA, Irmak S, Lisboa FA, Dizon AM, Warren JW, Ergun S, Dveksler GS: Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis. Biol Reprod 2010; 83:27-35.
87. Tilburgs T, Schonkeren D, Eikmans M, Nagtzaam NM, Datema G, Swings GM, Prins F, van Lith JM, van der Mast BJ, Roelen DL, Scherjon SA, Claas FH: Human decidual tissue contains differentiated CD8 + effector-memory T cells with unique properties. J Immunol 2010; 185:4470-4477.
88. Blois SM, Joachim R, Kandil J, Margni R, Tometten M, Klapp BF, Arck PC: Depletion of CD8 + cells abolishes the pregnancy protective effect of progesterone substitution with dydrogesterone in mice by altering the Th1/Th2 cytokine profile. J Immunol 2004; 172:5893-5899.
89. Harwood NE, Batista FD: Early events in B cell activation. Annu Rev Immunol 2010; 28:185-210.
90. Taylor PV, Hancock KW: Antigenicity of trophoblast and possible antigen-masking effects during pregnancy. Immunology 1975; 28:973-982.
91. Mowbray JF, Underwood JL: Immunology of abortion. Clin Exp Immunol 1985; 60:1-7.
92. Beard RW, Braude P, Mowbray JF, Underwood JL: Protective antibodies and spontaneous abortion. Lancet 1983; 2:1090.
93. Margni RA, Binaghi RA: Nonprecipitating asymmetric antibodies. Annu Rev Immunol 1988; 6:535-554.
94. Malan Borel I, Gentile T, Angelucci J, Pividori J, Guala MC, Binaghi RA, Margni RA: IgG asymmetric molecules with antipaternal activity isolated from sera and placenta of pregnant human. J Reprod Immunol 1991; 20:129-140.
95. Zenclussen AC, Gentile T, Kortebani G, Mazzolli A, Margni R: Asymmetric antibodies and pregnancy. Am J Reprod Immunol 2001; 45:289-294.
96. Shetty S, Ghosh K: Anti-phospholipid antibodies and other immunological causes of recurrent foetal loss-a review of literature of various therapeutic protocols. Am J Reprod Immunol 2009; 62:9-24.
97. Pierangeli SS, Chen PP, Raschi E, Scurati S, Grossi C, Borghi MO, Palomo I, Harris EN, Meroni PL: Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost 2008; 34:236-250.
98. Vinatier D, Dufour P, Cosson M, Houpeau JL: Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol 2001; 96:37-50.
99. Willis R, Harris EN, Pierangeli SS: Pathogenesis of the antiphospholipid syndrome. Semin Thromb Hemost 2012; 38:305-321.
100. Belizna CC, Richard V, Primard E, Kerleau JM, Cailleux N, Louvel JPMarie I, Hamidou M, Thuillez C, Lavesque H: Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding. Semin Arthritis Rheum 2008; 37:373-380.
101. Pierangeli SS, Vega-Ostertag M, Liu X, Girardi G: Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome. Ann N Y Acad Sci 2005; 1051:413-420.
102. Girardi G: Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome. Clin Rev Allergy Immunol 2010; 39:160-165.
103. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H, Luft FC: Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999; 103:945-952.
104. Walther T, Wallukat G, Jank A, Bartel S, Schultheiss SP, Faber R, Stepan H: Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension 2005; 46:1275-1279.
105. Dragun D, Müller DN, Bräsen JH, Fritsche L, Nieminen-Kelha M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, Mazak I, Plehm R, Schönemann C, Unger T, Budde K, Neumayer HH, Luft FC, Wallukat G: Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352:558-569.
106. Riemekasten G, Philippe A, Näther M, Slowinski T, Müller D, Heidecke H, Matucci-Cerinic M, Czirjak L, Lukitsch I, Becker M, Kill A, Van Laar JM, Catar R, Luft FC, Burmester GR, Hegner B, Dragun D: Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis 2011; 70:530-536.
107. Fu ML, Herlitz H, Schulze W, Wallukat G, Micke P, Eftekhari P, Sjögren KG, Hjalmarson A, Müller-Esterl W, Hoebeke J: Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens 2000; 18:945-953.
108. Wang W, Irani RA, Zhang Y, Ramin SM, Blackwell SC, Tao L, Kellems RE, Xia Y: Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia. Hypertension 2012; 60:712-721.
109. Zhou CC, Zhang Y, Irani RA, Zhang H, Mi T, Popek EJ, Hicks MJ, Ramin SM, Kellems RE, Xia Y: Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 2008; 14:855-862.
110. Zhou CC, Irani RA, Zhang Y, Blackwell SC, Mi T, Wen J, Shelat H, Geng YJ, Ramin SM, Kellems RE, Xia Y: Angiotensin receptor agonistic autoantibody- mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia. Circulation 2010; 121:436-444.
111. Jensen F, Wallukat G, Herse F, Budner O, El-Mousleh T, Costa SD, Dechend R, Zenclussen AC: CD19 + CD5 + cells as indicators of preeclampsia. Hypertension 2012; 59:861-868.
112. LaMarca B, Wallace K, Herse F, Wallukat G, Martin JN JrWeimer A, Dechend R: Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes. Hypertension 2011; 57:865-871.
113. Fest S, Aldo PB, Abrahams VM, Visintin I, Alvero A, Chen R, Chavez SL, Romero R, Mor G: Trophoblast-macrophage interactions: a regulatory network for the protection of pregnancy. Am J Reprod Immunol 2007; 57:55-66.
114. Ruttner Z, Ivanics T, Slaaf DW, Reneman RS, Ligeti L, Toth A: A novel model for the in vivo monitoring of uterine microcirculation and intracellular free calcium changes in rat. Microvasc Res 2000; 59:213-220.
115. Laschke MW, Schwender C, Scheuer C, Vollmar B, Menger MD: Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo. Hum Reprod 2008; 23:2308-2318.
116. Zenclussen AC, Olivieri DN, Dustin ML, Tadokoro CE: In vivo multiphoton microscopy technique to reveal the physiology of the mouse uterus. Am J Reprod Immunol 2012 Dec 24; doi:10.1111/aji.12066. [Epub ahead of print].
117. Zenclussen AC, Olivieri DN, Dustin ML, Tadokoro CE: In vivo multiphoton microscopy technique to reveal the physiology of the mouse placenta. Am J Reprod Immunol 2012; 68:271-278.
118. Holland OJ, Linscheid C, Hodes HC, Nauser TL, Gilliam M, Stone P, Chamley LW, Petroff MG: Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus. Am J Pathol 2012; 180:256-266.
119. Yang H, Qiu L, Di W, Zhao A, Chen G, Hu K, Lin Q: Proportional change of CD4 + CD25 + regulatory T cells after lymphocyte therapy in unexplained recurrent spontaneous abortion patients. Fertil Steril 2009; 92:301-305.
120. Zhou J, Wang Z, Zhao X, Wang J, Sun H, Hu Y: An increase of Treg cells in the peripheral blood is associated with a better in vitro fertilization treatment outcome. Am J Reprod Immunol 2012; 68:100-106.
121. Coulam CB, Acacio B: Does immunotherapy for treatment of reproductive failure enhance live births? Am J Reprod Immunol 2012; 67:296-304.